共有 50 笔近期内部人交易记录记录，涉及 MediciNova, Inc. (MNOV), 包括 35 笔买入 和 11 笔卖出. 内部人买入总额为 $14.79M 内部人卖出总额为 $824.22K.
近期活跃的重要内部人包括 Iwaki Yuichi, Matsuda Kazuko, Nagao Hideki. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — MNOV
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-01-16 |
Iwaki Yuichi |
President and CEO |
限制性股票授予 (RSU) |
450,000 |
$2.10 |
$945K |
450,000 |
| 2026-01-16 |
Matsuda Kazuko |
Chief Medical Officer |
限制性股票授予 (RSU) |
350,000 |
$2.10 |
$735K |
350,000 |
| 2025-06-17 |
Nagao Hideki |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-06-17 |
Beaver Carolyn |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-06-17 |
Lemerond Nicole |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.26 |
$25.2K |
20,000 |
| 2025-02-12 |
Iwaki Yuichi |
President and CEO |
限制性股票授予 (RSU) |
100,000 |
$1.84 |
$184K |
100,000 |
| 2025-02-12 |
Nagao Hideki |
Director |
限制性股票授予 (RSU) |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-02-12 |
Beaver Carolyn |
Director |
限制性股票授予 (RSU) |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-02-12 |
Matsuda Kazuko |
Chief Medical Officer |
限制性股票授予 (RSU) |
100,000 |
$1.84 |
$184K |
100,000 |
| 2025-02-12 |
Lemerond Nicole |
Director |
限制性股票授予 (RSU) |
24,500 |
$1.84 |
$45.08K |
24,500 |
| 2025-01-07 |
Iwaki Yuichi |
President and CEO |
限制性股票授予 (RSU) |
400,000 |
$1.52 |
$608K |
400,000 |
| 2025-01-07 |
Matsuda Kazuko |
Chief Medical Officer |
限制性股票授予 (RSU) |
300,000 |
$1.52 |
$456K |
300,000 |
| 2024-06-11 |
Nagao Hideki |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-06-11 |
Beaver Carolyn |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-06-11 |
Lemerond Nicole |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.34 |
$26.8K |
20,000 |
| 2024-01-09 |
Iwaki Yuichi |
President and CEO |
限制性股票授予 (RSU) |
210,000 |
$2.40 |
$504K |
210,000 |
| 2024-01-09 |
Matsuda Kazuko |
Chief Medical Officer |
限制性股票授予 (RSU) |
157,500 |
$2.40 |
$378K |
157,500 |
| 2024-01-09 |
Obrien Geoffrey |
Vice President |
限制性股票授予 (RSU) |
84,000 |
$2.40 |
$201.6K |
84,000 |
| 2023-08-04 |
Lemerond Nicole |
Director |
未知 |
- |
- |
- |
- |
| 2023-08-04 |
Lemerond Nicole |
Director |
限制性股票授予 (RSU) |
18,333 |
$2.47 |
$45.28K |
18,333 |
| 2023-06-13 |
Nagao Hideki |
Director |
限制性股票授予 (RSU) |
20,000 |
$2.23 |
$44.6K |
20,000 |
| 2023-06-13 |
Beaver Carolyn |
Director |
限制性股票授予 (RSU) |
20,000 |
$2.23 |
$44.6K |
20,000 |
| 2023-01-23 |
Iwaki Yuichi |
President and CEO |
限制性股票授予 (RSU) |
235,125 |
- |
- |
235,125 |
| 2023-01-23 |
Matsuda Kazuko |
Chief Medical Officer |
限制性股票授予 (RSU) |
149,625 |
- |
- |
149,625 |
| 2023-01-23 |
Obrien Geoffrey |
Vice President |
限制性股票授予 (RSU) |
76,950 |
- |
- |
76,950 |
| 2022-11-28 |
Nagao Hideki |
Director |
知情卖出 |
6,754 |
$2.25 |
$15.2K |
- |
| 2022-11-22 |
Nagao Hideki |
Director |
知情卖出 |
218 |
$2.13 |
$464.34 |
6,754 |
| 2022-11-21 |
Nagao Hideki |
Director |
知情卖出 |
5,365 |
$2.18 |
$11.7K |
6,972 |
| 2022-11-17 |
Nagao Hideki |
Director |
知情卖出 |
309 |
$2.18 |
$673.62 |
12,337 |
| 2022-06-16 |
Nagao Hideki |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2022-06-16 |
Beaver Carolyn |
Director |
限制性股票授予 (RSU) |
20,000 |
$2.51 |
$50.2K |
20,000 |
| 2022-06-16 |
Kruger Jason J |
Officer |
未知 |
- |
- |
- |
- |
| 2022-01-27 |
Iwaki Yuichi |
President and CEO |
限制性股票授予 (RSU) |
302,500 |
$5.92 |
$1.79M |
302,500 |
| 2022-01-27 |
Matsuda Kazuko |
Chief Medical Officer |
限制性股票授予 (RSU) |
192,500 |
$5.92 |
$1.14M |
192,500 |
| 2022-01-27 |
Obrien Geoffrey |
Vice President |
限制性股票授予 (RSU) |
99,000 |
$5.92 |
$586.08K |
99,000 |
| 2021-08-23 |
Matsuda Kazuko |
Chief Medical Officer |
期权行权（卖出） |
60,000 |
$2.30 |
$138K |
- |
| 2021-08-01 |
Paulin Douglas |
Officer |
未知 |
- |
- |
- |
- |
| 2021-07-09 |
Iwaki Yuichi |
President and CEO |
期权行权（卖出） |
39,583 |
$2.54 |
$100.54K |
- |
| 2021-06-24 |
Matsuda Kazuko |
Chief Medical Officer |
期权行权（卖出） |
56,250 |
$2.46 |
$138.38K |
- |
| 2021-06-16 |
Nagao Hideki |
Director |
限制性股票授予 (RSU) |
20,000 |
$3.95 |
$79K |
20,000 |
| 2021-06-16 |
Beaver Carolyn |
Director |
限制性股票授予 (RSU) |
20,000 |
$3.95 |
$79K |
20,000 |
| 2021-05-19 |
Obrien Geoffrey |
Vice President |
期权行权（卖出） |
32,000 |
$2.54 |
$81.28K |
- |
| 2021-04-22 |
Gaeta Federico C.a. |
Chief Scientific Officer |
处置 |
20,000 |
$5.42 |
$108.4K |
- |
| 2021-04-22 |
Gaeta Federico C.a. |
Chief Scientific Officer |
限制性股票授予 (RSU) |
24,000 |
$4.56 |
$109.44K |
24,000 |
| 2021-03-11 |
Nagao Hideki |
Director |
知情卖出 |
2,354 |
$7.40 |
$17.42K |
12,646 |
| 2021-02-25 |
Iwaki Yuichi |
President and CEO |
期权行权（卖出） |
86,250 |
$2.46 |
$212.18K |
- |
| 2021-02-02 |
Iwaki Yuichi |
President and CEO |
限制性股票授予 (RSU) |
495,000 |
$6.89 |
$3.41M |
495,000 |
| 2021-02-02 |
Matsuda Kazuko |
Chief Medical Officer |
限制性股票授予 (RSU) |
325,000 |
$6.89 |
$2.24M |
325,000 |
| 2021-02-02 |
Obrien Geoffrey |
Vice President |
限制性股票授予 (RSU) |
99,000 |
$6.89 |
$682.11K |
99,000 |
| 2021-01-11 |
3d Investment Partners Pte. Ltd. |
10 Percent Owner |
未知 |
456,637 |
- |
- |
- |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
